Medicine Startup Genexa Raises $60 Million From VC-Led Group
Over-the-counter medicine company Genexa Inc. raised $60 million of funding from venture-capital firms and celebrities.
How Two Dads Are Disrupting Medicine
The co-founders of an organic medicine company talk about their mission to revolutionize the over-the-counter industry.
Gwyneth Paltrow backs clean cold medicine
The cold and flu medicine category is a $3.2 billion industry.
The Latest News
Medicine Startup Genexa Raises $60 Million From VC-Led Group
In a space dominated by behemoths, Genexa Inc. raised $60 million of funding from venture-capital firms and celebrities.
Chain Drug Review - Genexa announces record-breaking Series A funding
Genexa has just completed its unprecedented $60 million Series A of funding to advance its market leadership in this emerging space.
Bloomberg Quicktake – Genexa leads the clean-up of OTC medicines
Max Spielberg, Co-Founder and President, talks live about his personal battle with allergens in medicines, how this prompted him and David Johnson to start Genexa, and why other companies have not done this already.
Fast Company – Are “clean meds” the next big wellness frontier?
Genexa was featured in Fast Company as the first clean medicine company leading the next big wellness frontier.
Forbes – How Genexa Is Leading The Clean Medicine Revolution And Getting Us To ‘Ditch The Dirty’
Afdhel Aziz chatted parent to parent with co-founders David Johnson and Max Spielberg about cleaning up the medicine aisle.
Entrepreneur – How Two Dads Are Disrupting Medicine
Genexa founders David Johnson and Max Spielberg sat down with Entrepreneur to share Genexa's mission to revolutionize the over-the-counter industry.